Comparative Efficacy of Two Doses of Nebulized Colistimethate for the Eradication of Pseudomonas Aeruginosa in Children with Cystic Fibrosis
BACKGROUND: Cystic fibrosis (CF) affects the respiratory and digestive systems. It evolves toward deterioration of pulmonary function through colonization with Pseudomonas aeruginosa. There is no consensus with respect to its eradication. Nebulized colistimethate is used for eradication treatment, b...
Main Authors: | Marie-Sophie Brochet, Anne-Catherine McDuff, Jean-François Bussières, Elaine Caron, Geneviève Fortin, Denis Lebel, Jacques-Édouard Marcotte |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2007-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2007/673976 |
Similar Items
-
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
by: P Tappenden, et al.
Published: (2013-12-01) -
Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate
by: Samrat Chatterjee, et al.
Published: (2016-01-01) -
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary infection
by: James Greenwood, et al.
Published: (2017-07-01) -
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
by: Amanda J. Morris, et al.
Published: (2021-08-01) -
No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
by: F. Claude, et al.
Published: (2019-03-01)